RNase Inhibitor, Recombinant

Recombinant Human Placental RNase Inhibitor (rHPRI) binds and inhibits a broad range of eukaryotic RNases, including RNase A, RNase B, RNase C, and human placental RNase.

N/A

50.0 kDa

Recombinant Human Placental RNase Inhibitor (rHPRI)

Recombinant Human Placental RNase Inhibitor (rHPRI)

Yes

E. coli strain containing an overproducing clone of human placenta ribonuclease inhibitor.

≥90%

SDS-PAGE, N/A

N/A

40 unit/μl

N/A

N/A

N/A

One unit inhibits the activity of 5 ng of RNase A by 50%.

-20°C

Gel pack

Liquid

Recombinant RNase Inhibitor in 20 mM HEPES (pH 7.6), 50 mM KCl, 8 mM DTT and 50% glycerol.

N/A

N/A

Centrifuge the vial prior to opening.

For Research Use Only! Not to be used in humans

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Recombinants or rec. proteins

recombinants